Impact of Probiotics on Antibiotic-associated Diarrhea in Community-acquired Pneumonia

Sponsor
National Health Insurance Service Ilsan Hospital
Study ID
NCT06990568
Phase
PHASE4
Status
Not Yet Recruiting

Notify me when recruiting opens

Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.

Not yet recruiting

Add your contact details and location so we can keep your interest tied to this study.

Conditions

  • Diarrhea
  • Pneumonia
  • Probiotics

Eligibility Criteria

Sex
ALL
Age
19 Years - 79 Years
Healthy Volunteers
Not accepted

Interventions

  • Lacidofil — DRUG
    1 capsule twice daily.
  • Placebo — DRUG
    1 capsule twice daily.

Study Details

The study goal is to determine whether oral administration of a probiotic mixture can reduce the incidence of antibiotic-associated diarrhea in patients with community-acquired pneumonia.

Key Dates

First listed
May 25, 2025
Start date
Jun 1, 2025
Status verified
May 2025
Primary completion
May 31, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
100 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
PREVENTION

Arms

  • Experimental: Lacidofil
    Take 1 capsule of Lacidofil in the morning and evening after meals, for a total of 2 times a day. The total duration of the dosage is the antibiotic treatment period plus 5 days.
  • Placebo Comparator: Placebo
    Take 1 capsule of placebo in the morning and evening after meals, for a total of 2 times a day. The total duration of the dosage is the antibiotic treatment period plus 5 days.

Primary Outcome Measure

Occurrence of antibiotic-associated diarrhea [ Time Frame: Within 14 days after the cessation of Lacidofil or placebo administration ]

Central Contacts

Related Studies